Marksans Pharma Limited

MARKSANS.NS·NSE·Healthcare
Compare
313.75+12.10 (+4.01%)today
At close: Nov 5, 3:30 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close301.65
Open307.00
Day range300.35316.25
52-week range155.00350.95
Off day high−0.79%
Off 52-week high−10.60%
Volume2.10M
Avg. volume (3M)3.33M
Market cap142.20B
EPS (TTM)12.35
Forward P/E22.30
P/E ratio (TTM)25.40
Dividend yield0.30% (0.9000)
Beta (5Y)1.11
Shares outstanding453.22M
Short interest—
Earnings dateAug 11, 2025
Analyst target324.33
Profit margin16.29%

Against its peers

Compare in full ›
MARKSANS.NS MRK KOPRAN.BO SOLARA.NS STAR.BO IOLCP.NS
Market cap 142.20B 370.96B 12.80B 31.04B 92.73B 55.50B
P/E (TTM) 25.4 151.9 51.2 83.4 15.0 27.3
Forward P/E 22.3 16.7 39.7 20.5 11.7 17.5
Price/book 4.3 8.9 2.4 2.2 2.7 2.9
Dividend yield 0.30% 2.26% 1.25% — 0.49% 0.54%
1-year change +63.43% +75.29% +56.40% +14.61% +5.44% +102.86%
Today +4.01% +3.93% +5.79% −0.25% −0.58% +2.89%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Multibagg AI·Negative

Marksans Pharma Limited to report Q2 FY27 results November 4

Marksans Pharma Limited is scheduled to consider and approve its unaudited standalone and consolidated Q2 FY27 results on November 4, 2026, following Q1 revenue reported as 840 and year-on-year growth of 35.62%. The board meeting will also…

From the 4Search news index, newest first.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance